Skip to content

Fluorouracil

Published: July 26, 2026Updated: August 24, 2026

Fluorouracil is an antimetabolite chemotherapy medication used to treat various cancers including colorectal, breast, gastric, pancreatic, and certain skin cancers. It works by interfering with DNA and RNA synthesis in rapidly dividing cells, ultimately inhibiting cell growth and reproduction.

Quick summary

Fluorouracil is a chemotherapy drug that inhibits cancer cell growth by disrupting DNA and RNA synthesis.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 24, 2026Editorial policy

Key facts at a glance

ATC
L01BC02
RxNorm
4492
Generic
Fluorouracil
Class
atc-l01
Brands
Tolak, Adrucil, Fluoroplex, Efudex, Favlyxa, Carac
Availability
rx
Lactation
unknown
Routes
topical, oral
Forms
injection, cream, solution, capsule
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
500mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
250mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
400mg daily
Maximum
consult physician
Frequency
once daily
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Single dose exceeding 10 grams may cause serious or fatal toxicity
Chronic overdose: Cumulative doses above recommended limits can lead to severe myelosuppression, mucositis, and organ damage
Immediate actions
Gastric lavage if within 1-2 hours, activated charcoal, supportive care, hydration, monitor blood counts
Antidote
Uridine triacetate (Vistogard)(Effective when administered within 96 hours of overdose)
Poison Control: 1-800-222-1222

Special Populations

10 groups
✗

pregnancy

first trimester
unsafe
FDA Category
D
Dose Adjustment

avoid

Key Recommendations

avoid use during pregnancy unless benefits outweigh risks to the mother outweigh potential harm to fetus

Monitor

regular fetal monitoring and ultrasound examinations

Use of this medication in this population requires careful consideration of risks and benefits.

✗

pregnancy

second trimester
unsafe
FDA Category
D
Dose Adjustment

avoid

Key Recommendations

avoid use during pregnancy unless benefits outweigh risks

Monitor

regular fetal monitoring

Use of this medication in this population requires careful consideration of risks and benefits.

✗

pregnancy

third trimester
unsafe
FDA Category
D
Dose Adjustment

avoid

Key Recommendations

avoid use near term due to risk of fetal toxicity and complications

Monitor

fetal monitoring and assessment of fetal growth

Use of this medication in this population requires careful consideration of risks and benefits.

✗

lactation

breastfeeding
contraindicated
FDA Category
D
Dose Adjustment

discontinue breastfeeding

Key Recommendations

do not breastfeed during treatment and for at least 1 week after last dose

Monitor

not applicable

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

geriatric

elderly
caution
FDA Category
N
Dose Adjustment

consider dose reduction based on organ function

Key Recommendations

use with caution due to potential decreased hepatic and renal function; monitor for adverse effects

Monitor

regular monitoring of renal and hepatic function, complete blood counts

Use with caution and monitor for adverse effects.

⚠

pediatric_age

children adolescents
caution
FDA Category
D
Dose Adjustment

weight-based dosing with careful monitoring

Key Recommendations

used in pediatric oncology; dosing based on body surface area; requires specialized pediatric oncology management

Monitor

frequent complete blood counts, liver function tests, and close monitoring for toxicity

Use with caution and monitor for adverse effects.

⚠

renal_impairment

mild to moderate
caution
FDA Category
N
Dose Adjustment

no standard dose reduction; monitor closely

Key Recommendations

use with caution; fluorouracil is primarily metabolized hepatically but monitor renal function

Monitor

monitor renal function and adjust dose based on toxicity

Use with caution and monitor for adverse effects.

⚠

renal_impairment

severe
caution
FDA Category
N
Dose Adjustment

consider dose reduction

Key Recommendations

use with caution in severe renal impairment; consider dose reduction and close monitoring

Monitor

frequent monitoring of renal function and blood counts

Use with caution and monitor for adverse effects.

⚠

hepatic_impairment

mild
caution
FDA Category
N
Dose Adjustment

no standard dose adjustment; monitor closely

Key Recommendations

use with caution; fluorouracil is extensively metabolized in liver

Monitor

monitor liver function tests and for signs of hepatotoxicity

Use with caution and monitor for adverse effects.

✗

hepatic_impairment

moderate to severe
unsafe
FDA Category
D
Dose Adjustment

significant dose reduction or avoid

Key Recommendations

use with extreme caution or avoid in moderate to severe hepatic impairment due to altered metabolism

Monitor

frequent liver function monitoring, bilirubin, and clinical assessment

Use of this medication in this population requires careful consideration of risks and benefits.

Statistics and clinical data

prescribingFDA
2023

Commonly prescribed since

Value:1960s

General prescribing information

drug_classWHO
2023

Drug class

Value:Antimetabolite (Pyrimidine Analog)

Drug class information

usageMedical guidelines
2023

Common uses

Value:Treatment of colorectal, breast, gastric, pancreatic, and other cancers

Common therapeutic uses

mechanismFDA
2023

Mechanism of action

Value:Inhibits thymidylate synthase and incorporates into RNA/DNA

Pharmacological mechanism

Treats colorectal cancer (often with leucovorin), breast cancer, gastric cancer, pancreatic cancer, and topical forms are used for actinic keratosis and superficial basal cell carcinoma.

Fluorouracil is converted to active metabolites that inhibit thymidylate synthase, blocking DNA synthesis. It is also incorporated into RNA and DNA, causing cell death in rapidly dividing cancer cells.

Can cause significant bone marrow suppression, mucositis, nausea, diarrhea, and hand-foot syndrome. Topical use may cause local skin reactions. Contraindicated in pregnancy (Category D) and in patients with known dihydropyrimidine dehydrogenase (DPD) deficiency. Requires regular blood count monitoring during treatment.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 24, 2026. · Read our editorial policy